TRPM7 Gene Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex Susceptibility to NGS Genetic DNA Test
Introduction
The TRPM7 Gene Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex Susceptibility to NGS Genetic DNA Test is a groundbreaking diagnostic tool designed to assess genetic risk factors associated with severe neurological disorders. This test leverages Next-Generation Sequencing (NGS) technology to provide comprehensive insights into genetic predispositions, making it an essential resource for individuals concerned about their neurological health.
What the Test Measures
This genetic test specifically measures the susceptibility to amyotrophic lateral sclerosis (ALS), parkinsonism, and dementia complex linked to the TRPM7 gene. By analyzing the patient’s genetic material, healthcare providers can identify potential risk factors that may predispose them to these debilitating conditions.
Who Should Consider This Test?
Individuals with a family history of neurological disorders, particularly those related to ALS, parkinsonism, and dementia, should consider this test. Symptoms such as muscle weakness, cognitive decline, or movement difficulties may also indicate the need for genetic testing. Consulting a neurologist can help determine if this test is appropriate based on clinical history and risk factors.
Benefits of Taking the Test
- Identifies genetic predispositions to neurological disorders.
- Guides treatment and management strategies.
- Provides valuable information for family planning and genetic counseling.
- Helps in understanding the hereditary nature of these conditions.
Understanding Your Results
Results from the TRPM7 Gene test can provide insights into your genetic risk for developing ALS, parkinsonism, and dementia. It is essential to discuss these results with a qualified healthcare professional who can help interpret the findings and recommend appropriate next steps.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| TRPM7 Gene Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex Susceptibility to NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Test Details
- Turnaround Time: 3 to 4 Weeks
- Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
- Pre-Test Instructions: A clinical history of the patient and a genetic counseling session to draw a pedigree chart of family members affected with the TRPM7 gene disorders.
Book Your Test Today!
We have branches across all major cities in Kenya, including Nairobi, Mombasa, and Kisumu, and offer home sample collection services for your convenience. To book the TRPM7 Gene Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex Susceptibility to NGS Genetic DNA Test, please call or WhatsApp us at +254711564616.
